Correlation Between SAB Biotherapeutics and Biovaxys Technology

Can any of the company-specific risk be diversified away by investing in both SAB Biotherapeutics and Biovaxys Technology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SAB Biotherapeutics and Biovaxys Technology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between SAB Biotherapeutics and Biovaxys Technology Corp, you can compare the effects of market volatilities on SAB Biotherapeutics and Biovaxys Technology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SAB Biotherapeutics with a short position of Biovaxys Technology. Check out your portfolio center. Please also check ongoing floating volatility patterns of SAB Biotherapeutics and Biovaxys Technology.

Diversification Opportunities for SAB Biotherapeutics and Biovaxys Technology

0.26

Correlation Coefficient

SAB Biotherapeutics  Biovaxys Technology

Modest diversification

The 3 months correlation between SAB and Biovaxys is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding SAB Biotherapeutics and Biovaxys Technology Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biovaxys Technology Corp and SAB Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SAB Biotherapeutics are associated (or correlated) with Biovaxys Technology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biovaxys Technology Corp has no effect on the direction of SAB Biotherapeutics i.e., SAB Biotherapeutics and Biovaxys Technology go up and down completely randomly.

Pair Corralation between SAB Biotherapeutics and Biovaxys Technology

Given the investment horizon of 90 days SAB Biotherapeutics is expected to generate 1.73 times more return on investment than Biovaxys Technology. However, SAB Biotherapeutics is 1.73 times more volatile than Biovaxys Technology Corp. It trades about 0.18 of its potential returns per unit of risk. Biovaxys Technology Corp is currently generating about 0.03 per unit of risk. If you would invest  303.00  in SAB Biotherapeutics on September 25, 2024 and sell it today you would earn a total of  125.00  from holding SAB Biotherapeutics or generate 41.25% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

SAB Biotherapeutics  vs.  Biovaxys Technology Corp

SAB Biotherapeutics

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in SAB Biotherapeutics are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak fundamental drivers, SAB Biotherapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Biovaxys Technology Corp

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Biovaxys Technology Corp are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Biovaxys Technology reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with SAB Biotherapeutics and Biovaxys Technology

The main advantage of trading using opposite SAB Biotherapeutics and Biovaxys Technology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SAB Biotherapeutics position performs unexpectedly, Biovaxys Technology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biovaxys Technology will offset losses from the drop in Biovaxys Technology's long position.

The idea behind SAB Biotherapeutics and Biovaxys Technology Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.